We offer a complete portfolio of surgical products for cataract, retinal, refractive and corneal surgery.
Investors 1
| Date | Name | Website |
| - | Wellington... | wellington... |
Mentions in press and media 1
| Date | Title | Description |
| 07.12.2011 | Avedro lands orphan status for corneal ectasia treatment | Regulatory Roundup | Avedro Inc. won an orphan drug designation for a solution used with its KXL irradiation system to treat corneal ectasia following refractive surgery. The decision sets the Waltham, Mass.-based company up for 7 years of exclusive rights to t... |